Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity
Main Authors: | Derek J. Hausenloy, MD, PhD, Choon Ta Ng, MD, Jun Hua Chong, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | JACC. CardioOncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087320300065 |
Similar Items
-
Preventing the Cancer Patient of Today From Becoming the Heart Failure Patient of Tomorrow∗
by: Derek M. Yellon, PhD, DSc, et al.
Published: (2019-12-01) -
Remote ischemic conditioning: from bench to bedside
by: Derek John Hausenloy, et al.
Published: (2012-02-01) -
Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review
by: Izabela Koss-Mikołajczyk, et al.
Published: (2021-09-01) -
Kinetics and Signal Activation Properties of Circulating Factor(s) From Healthy Volunteers Undergoing Remote Ischemic Pre-Conditioning
by: Heike A. Hildebrandt, MD, et al.
Published: (2016-01-01) -
A TRICk to Improve the Effectiveness of RIC: Role of Limb Temperature in Enhancing the Effectiveness of Remote Ischemic Conditioning
by: Claudia Penna, et al.
Published: (2022-01-01)